MedTrace Logo

Method of Genetic Analysis in Genodermatoses

NCT03873285 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-04-16

No results posted yet for this study

Summary

The goal of the study is to develop a method of genetic diagnosis in two stages, by mendelioma then by genome and transcriptome on fibroblast culture, in genodermatoses and rare diseases with cutaneous expression in the child.

Conditions

  • Genodermatosis
  • Rare Genetic Disease With Cutaneous Expression

Interventions

GENETIC

Genetic diagnostic by mendeliome or genome

For cases not explained by a mendeliomes: genome and transcriptome on fibroblast culture

Sponsors & Collaborators

  • Center of Human Genetics - ULB in Brussels

    collaborator UNKNOWN

  • Interuniversity Institute of Bioinformatics in Brussels

    collaborator UNKNOWN

  • Queen Fabiola Children's University Hospital

    lead OTHER

Principal Investigators

  • Deborah Salik, MD · Hôpital Universitaire Des Enfants Rein Fabiola

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-27
Primary Completion
2021-11-30
Completion
2021-11-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03873285 on ClinicalTrials.gov